Tarceva effective in treating certain type of lung cancer
there has been a lot of talking this weekend about an old drug Tarceva that may
find new use in treating lung cancer after a press release issued on Friday by
OSI Pharmaceuticals Inc and Genentech.
The drug makers said a new yet small study showed the
drug Tarceva effectively slowed the progression of lung cancer when given
immediately after chemotherapy.
Another study published early this year but not as widely
publicized suggests that taking vitamin D supplements could reduce the risk of
lung cancer by 70 percent in young men and women.
The details of the drug trial will reportedly be
presented at an upcoming medical conference and will be also submitted to
federal regulators for approval of Tarceva for expanded use in treating lung
The drug has been Okayed by the U.S. government in 2004
to treat patients with locally advanced or metastatic non-small cell lung
cancer, the most common form of lung cancer in the U.S in cases other
treatments have failed to stop progression of the disease.
An early trial showed that patients receiving Tarceva had
a median survival of 6.7 months compared to 4.7 months for those who were given
This new study is good news that OSI and its partners
In early trials, Traceva
failed to deliver much of additional benefit when used along with Avastin, a
cancer drug made by Genentech.
High serum vitamin D cuts lung cancer risk in young
people by 70 percent
Lung cancer is very dangerous and prognosis for the
disease is very poor.
Thus no one can
afford to wait to develop the disease and then treat it.
According to data from the U.S. government,
more than 200,000 people in the U.S. are diagnosed and more than 160,000 die
from the disease each year.
Is there anything we can do in reality to prevent lung
We have already known that physical activity, diet high
in fruits and vegetables, high in nutrients like vitamin C, E, or selenium may
reduce the risk of lung cancer.
exposure to sunlight and or taking vitamin D supplements, getting enough sleep,
avoiding stress and fatigue and environmental pollutants may also help.
A new study published in the Nov 2008 issue of Cancer
Epidemiol Biomarkers Prev. showed once again that high levels of serum
25-hydroxyvitamin D [25(OH)D] level was linked with reduced risk of lung
For the prospective cohort study, Kilkkinen A and
colleagues of the National Public Health Institute in Helsinki, Finland looked
at data on serum vitamin D levels and cases of lung cancer for 6,937 men and
During a maximum follow-up of 24
years, 122 cases of lung cancer were recorded.
An association between vitamin D and lung cancer risk was
observed for the highest versus lowest tertile with the odds ratio 0.72.
But the researchers said the link was not
However, the significant association was found among
women and young men and women.
For women, those who had highest levels of vitamin D in
their blood were 84 percent less likely to develop lung cancer.
For younger participants, those with highest
levels were 66 percent less likely to have the disease compared to those with
the lowest levels.
The researchers concluded that "although there was
no overall association between vitamin D and lung cancer risk, women and young
participants with a higher level of vitamin D were observed to have a lower
lung cancer risk."
The study was not a trial, but there is a very good
chance that the association is a causal relationship.
Laboratory studies have already yielded
evidence suggesting that vitamin D suppresses lung carcinogenesis.
Disclaimer: What's published on this website should be considered opinions of respective writers only and foodconsumer.org which has no political agenda nor commercial ambition may or may not endorse any opinion of any writer. No accuracy is guaranteed although writers are doing their best to provide accurate information only.
The information on this website should not be construed as medical advice and should not be used to replace professional services provided by qualified or licensed health care workers. The site serves only as a platform for writers and readers to share knowledge, experience, and information from the scientific community, organizations, government agencies and individuals.
Foodconsumer.org encourages readers who have had medical conditions to consult with licensed health care providers - conventional and or alternative medical practitioners.